QGEN

QIAGEN N.V. QGEN

NYSELarge CapHealthcare
InternationalScored off the official board: an annual-only filer, so this data lags a domestic quarterly filer.

13F Pro quality score

Rank #1,158 of 2,925TOP 50%

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$2.09B

Quarter to Dec 31

Net income

$424.88M

Quarter to Dec 31

Free cash flow

$453.28M

Quarter to Dec 31

Operating margin

22.3%

Quarter to Dec 31

Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

Operating Margin

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Debt/Equity

FY 2025
EDGAR

Loading ratio trend…

About QIAGEN N.V. (QGEN): stock profile, AI score and financials

QIAGEN N.V. (QGEN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores QGEN at 56.4/100 on a composite quality score built from its SEC filings, placing it at rank #1,158 of 2,925 stocks — the top half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), QIAGEN N.V. reports quarterly revenue of $2.1B, net income of $424.9M, an operating margin of 22.3%. QGEN trades on the NYSE exchange and files with the SEC under CIK 1015820. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate QGEN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for QIAGEN N.V. directly from SEC EDGAR.

SEC EDGAR: CIK 1015820 →